An overview of terrorism and its impact on biomedical research facilities

Lab Animal
John M Hicks

Abstract

Since the '9/11' and anthrax-contaminated-letter events of 2001, American society has given the term "bioterrorism" much attention. The author clarifies the definitions associated with bioterrorism and terrorism, provides an historical perspective regarding bioweapons, defines and characterizes the types of agents used as bioweapons, reviews pertinent bioterrorism legislation, and concludes by assessing the impact of these elements on biomedical research facilities.

References

Jun 15, 1999·JAMA : the Journal of the American Medical Association·D A HendersonK Tonat
Dec 19, 2001·Emerging Infectious Diseases·M I MeltzerJ D Millar
Jun 29, 2002·Applied and Environmental Microbiology·Pradeep K MalakarK van 't Riet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.